| Alternative Name: | Interleukin-19, Melanoma differentiation associated-like protein |
| |
| MW: | ~17.9 kDa |
| |
| Source: | Produced in E. coli. Contains 154 amino acids. |
| |
| UniProt ID: | Q9UHD0 |
| |
| Formulation: | Lyophilized from a sterile (0.2 micron) filtered solution containing 0.1% Trifluoroacetic Acid (TFA). |
| |
| Purity: | ≥95% (SDS-PAGE) |
| |
| Endotoxin Content: | ≤1 EU/µg protein (LAL test) |
| |
| Reconstitution: | Reconstitute in sterile water at 0.1 mg/mL. |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | -80°C |
| |
| Handling: | Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -80°C. For long term storage, it is recommended to dilute to working aliquots in a 0.1% BSA solution. |
| |
| Scientific Background: | Interleukin-19 (IL-19) is produced by B cells and monocytes. IL-19 binds the interleukin 20 receptor complex to activate STAT3 signaling. IL-19 induces IL-6 and tumor necrosis factor alpha (TNF-α) expression in monocytes, and promotes T helper 2 cell-mediated immune responses. IL-19 production is up-regulated in resting monocytes following granulocyte-macrophage colony-stimulating factor (GM-CSF) or lipopolysaccharide (LPS) stimulation. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
